Literature DB >> 27895176

The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants.

Hanif Javanmard Khameneh1, Adrian W S Ho1, Roberto Spreafico1, Heidi Derks1, Hazel Q Y Quek1, Alessandra Mortellaro2.   

Abstract

Despite a long history and extensive usage of insoluble aluminum salts (alum) as vaccine adjuvants, the molecular mechanisms underpinning Ag-specific immunity upon vaccination remain unclear. Dendritic cells (DCs) are crucial initiators of immune responses, but little is known about the molecular pathways used by DCs to sense alum and, in turn, activate T and B cells. In this article, we show that alum adjuvanticity requires IL-2 specifically released by DCs, even when T cell secretion of IL-2 is intact. We demonstrate that alum, as well as other sterile particulates, such as uric acid crystals, induces DCs to produce IL-2 following initiation of actin-mediated phagocytosis that leads to Src and Syk kinase activation, Ca2+ mobilization, and calcineurin-dependent activation of NFAT, the master transcription factor regulating IL-2 expression. Using chimeric mice, we show that DC-derived IL-2 is required for maximal Ag-specific proliferation of CD4+ T cells and optimal humoral responses following alum-adjuvanted immunization. These data identify DC-derived IL-2 as a key mediator of alum adjuvanticity in vivo and the Src-Syk pathway as a potential leverage point in the rational design of novel adjuvants.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27895176      PMCID: PMC5164880          DOI: 10.4049/jimmunol.1600420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β.

Authors:  Amir S Yazdi; Greta Guarda; Nicolas Riteau; Stefan K Drexler; Aubry Tardivel; Isabelle Couillin; Jürg Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes.

Authors:  Gianluca Fossati; Robert J Moots; Roger C Bucknall; Steven W Edwards
Journal:  Arthritis Rheum       Date:  2002-05

3.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

4.  Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

Authors:  Amanda L Gavin; Kasper Hoebe; Bao Duong; Takayuki Ota; Christopher Martin; Bruce Beutler; David Nemazee
Journal:  Science       Date:  2006-12-22       Impact factor: 47.728

5.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis.

Authors:  F Granucci; C Vizzardelli; N Pavelka; S Feau; M Persico; E Virzi; M Rescigno; G Moro; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells.

Authors:  Kristin Hochweller; Jörg Striegler; Günter J Hämmerling; Natalio Garbi
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

7.  Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice.

Authors:  Sonia Feau; Valeria Facchinetti; Francesca Granucci; Stefania Citterio; David Jarrossay; Samantha Seresini; Maria Pia Protti; Antonio Lanzavecchia; Paola Ricciardi-Castagnoli
Journal:  Blood       Date:  2004-09-07       Impact factor: 22.113

8.  Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.

Authors:  Markus P Radsak; Helmut R Salih; Hans-Georg Rammensee; Hansjörg Schild
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

Authors:  Amy S McKee; Michael W Munks; Megan K L MacLeod; Courtney J Fleenor; Nico Van Rooijen; John W Kappler; Philippa Marrack
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

10.  Dynamic recruitment of phospholipase C gamma at transiently immobilized GPI-anchored receptor clusters induces IP3-Ca2+ signaling: single-molecule tracking study 2.

Authors:  Kenichi G N Suzuki; Takahiro K Fujiwara; Michael Edidin; Akihiro Kusumi
Journal:  J Cell Biol       Date:  2007-05-21       Impact factor: 10.539

View more
  11 in total

Review 1.  Developments in Vaccine Adjuvants.

Authors:  Farrhana Ziana Firdaus; Mariusz Skwarczynski; Istvan Toth
Journal:  Methods Mol Biol       Date:  2022

2.  Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement.

Authors:  Carmela Gallo; Emiliano Manzo; Giusi Barra; Laura Fioretto; Marcello Ziaco; Genoveffa Nuzzo; Giuliana d'Ippolito; Francesca Ferrera; Paola Contini; Daniela Castiglia; Claudia Angelini; Raffaele De Palma; Angelo Fontana
Journal:  Cell Mol Life Sci       Date:  2022-06-20       Impact factor: 9.207

3.  CD83 orchestrates immunity toward self and non-self in dendritic cells.

Authors:  Andreas B Wild; Lena Krzyzak; Katrin Peckert; Lena Stich; Christine Kuhnt; Alina Butterhof; Christine Seitz; Jochen Mattner; Niklas Grüner; Maximilian Gänsbauer; Martin Purtak; Didier Soulat; Thomas H Winkler; Lars Nitschke; Elisabeth Zinser; Alexander Steinkasserer
Journal:  JCI Insight       Date:  2019-10-17

Review 4.  Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.

Authors:  Kamila Bendickova; Federico Tidu; Jan Fric
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

Review 5.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

6.  Activation of the NLRP3 Inflammasome by Particles from the Echinococcus granulosus Laminated Layer.

Authors:  Cecilia Casaravilla; Álvaro Pittini; Dominik Rückerl; Judith E Allen; Álvaro Díaz
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

7.  Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis.

Authors:  Andrea Mencarelli; Hanif Javanmard Khameneh; Jan Fric; Maurizio Vacca; Sary El Daker; Baptiste Janela; Jing Ping Tang; Sabrina Nabti; Akhila Balachander; Tong Seng Lim; Florent Ginhoux; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  Nat Commun       Date:  2018-03-16       Impact factor: 14.919

Review 8.  Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines.

Authors:  Laura Gornati; Ivan Zanoni; Francesca Granucci
Journal:  Front Immunol       Date:  2018-06-27       Impact factor: 7.561

9.  A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Wilma Patrícia de Oliveira Santos Bernardes; Mariana Moreira Mendes; Sergio Costa Oliveira; Cristina Toscano Fonseca
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

10.  Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease.

Authors:  Xintao Gao; Xiao Ren; Shan Zhang; Haozhi Song; Xiaoyu Guo; Hong Jia; Ting Xin; Yitong Jiang; Zhifang Zhang; Shaohua Hou
Journal:  Poult Sci       Date:  2020-08-28       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.